Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 105,701 shares at $200.00 ($21.1M) on 2019-10-31, disclosed to the SEC on 2019-11-04.
Open-market sale of $21.1M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.00 | 8,879 | $1.8M | 8.4% |
| 2 | $200.00 | 70,290 | $14.1M | 66.5% |
| 3 | $200.06 | 26,532 | $5.3M | 25.1% |
| Total | $200.02 avg | 105,701 | $21.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |